Hyaluronic Acid Cosmetic Testing: Molecular Weight, Purity Grades, and Stability for Skincare Formulations

Hyaluronic acid is not one ingredient — it is a family of sodium hyaluronate grades differentiated by molecular weight, fermentation source, purity tier, and endotoxin profile. A 1.5 MDa film-forming polymer and a 10 kDa penetration-positioned oligomer behave differently in formulation, perform differently on skin, and require different analytical programs to release. Brands that treat “hyaluronic acid” as a single line item on a CoA are building claims on incomplete data.

At Qalitex, we have seen HA testing volume roughly triple since 2022, driven by multi-weight serum formats and the post-procedure skincare segment where endotoxin documentation matters. The analytical toolkit is well established — SEC-HPLC, LAL, viscometry, UV-based protein residuals — but the specification-setting process is where most brands underperform. This article walks through the core tests, the numbers that matter, and how to structure a release program that survives both a retailer audit and a formulation failure investigation.

Molecular weight characterization by SEC-HPLC

Molecular weight is the defining quality attribute for sodium hyaluronate in skincare. Marketing copy references “low molecular weight HA” or “multi-depth delivery” — the lab work behind those phrases is size-exclusion chromatography (SEC), also called gel-permeation chromatography (GPC), coupled to refractive index (RI) detection and, where absolute Mw values are needed, multi-angle light scattering (MALS).

For raw material and ingredient-level verification, Ayah Labs specializes in contract testing and supplier qualification.

For EU market entry and European regulatory compliance, Care Europe provides expert consulting from Paris.

At Qalitex, we run SEC-HPLC on a TSKgel G6000PWxl column (7.8 mm × 300 mm) with a TSKgel guard column, using 0.1 M NaNO₃ mobile phase at 0.5 mL/min flow rate and 35 °C column temperature. Detection is by RI with optional MALS for weight-average molecular weight (Mw) determination without reliance on pullulan or dextran calibration curves. Injection volume is 100 µL of a 1.0 mg/mL solution in mobile phase. Run time is 40 minutes.

The industry uses three broad MW bands, though suppliers are not always consistent in where they draw the boundaries:

MW classification	Weight-average Mw range	Typical application	Formulation behavior
Low MW (oligo-HA)	< 50 kDa	Penetration serums, post-procedure recovery	Low viscosity, watery feel, fast absorption narrative
Medium MW	100–500 kDa	Balanced hydration serums, gel creams	Moderate viscosity, good film with lighter sensory
High MW	> 1,000 kDa (1 MDa)	Occlusive film formers, sheet mask serums	High viscosity, surface-level moisture barrier

The gap between 50 kDa and 100 kDa is intentional — material in that range is less common commercially and sometimes falls between supplier marketing categories. If your supplier spec says “low molecular weight” but the SEC chromatogram shows a Mw of 80 kDa, you are in an ambiguous zone. Define numeric Mw acceptance criteria — not categorical labels — in your quality agreement.

Polydispersity index (PDI) is the other SEC output worth tracking. PDI = Mw/Mn, where Mn is the number-average molecular weight. A PDI near 1.0 indicates a narrow, well-controlled distribution. Fermentation-derived HA typically shows PDI of 1.2–2.0. Enzymatically degraded low-MW grades often produce PDI of 1.5–3.0 with a high-MW tail that alters viscosity and sensory in ways the average Mw alone does not predict. Request the full SEC trace, not just the reported Mw value.

Purity specifications and protein residuals

Sodium hyaluronate produced by microbial fermentation (typically Streptococcus equi subsp. zooepidemicus or engineered Bacillus subtilis) carries process-related impurities: residual proteins from the host organism, nucleic acids, and fermentation media components. Purity specifications should cover both chemical identity and biological residuals.

Parameter	Cosmetic-grade spec	Pharmaceutical / injectable reference	Method
Assay (sodium hyaluronate, dry basis)	≥ 90.0%	≥ 95.0%	Carbazole or CTAB turbidimetric
Loss on drying	≤ 10.0%	≤ 10.0%	105 °C, 3 hours
pH (1% solution)	5.0–8.5	6.0–7.5	Potentiometric
Protein residuals	≤ 0.1% (w/w)	≤ 0.05% (w/w)	Bradford or Lowry (UV 280 nm)
Nucleic acids	≤ 0.1%	≤ 0.05%	UV absorbance at 260 nm
Heavy metals (as Pb)	≤ 20 ppm	≤ 10 ppm	ICP-MS

At Qalitex, we quantitate protein residuals by the Bradford method (Coomassie Brilliant Blue G-250 binding, measured at 595 nm) with BSA calibration curve, validated LOQ of 0.005% (w/w). This catches host-cell proteins that UV 280 nm absorbance alone can undercount in the presence of HA’s own UV absorption tail.

Brands sourcing fermentation-derived HA from Chinese or Korean suppliers should request protein residual data on every incoming lot. We have seen lot-to-lot protein content swing from 0.02% to 0.18% within the same supplier — well-controlled fermentation keeps this under 0.05%, but downstream purification shortcuts show up immediately in the Bradford result.

Nucleic acid content above 0.1% may not pose a safety risk in a topical cosmetic, but it signals incomplete purification and correlates with higher endotoxin loads. Treat nucleic acid testing as a process indicator, not just a pass/fail gate.

Endotoxin screening: when and why it matters

Bacterial endotoxins (lipopolysaccharides from gram-negative organisms) are a mandatory test for injectable hyaluronic acid fillers under USP <85>. For topical cosmetics, no pharmacopeial endotoxin requirement exists. That does not mean endotoxin is irrelevant.

Three commercial scenarios push topical HA brands toward endotoxin testing:

1. Post-procedure serums marketed for use after microneedling, laser resurfacing, or chemical peels — the skin barrier is compromised, and endotoxin on a disrupted barrier can provoke inflammatory responses
2. Medical-adjacent positioning where marketing targets dermatology clinics or medspa channels that expect pharmaceutical-style documentation
3. Export to markets (Japan, EU) where cosmetic GMP auditors increasingly ask for endotoxin data on fermentation-derived ingredients as part of biological safety documentation

At Qalitex, we perform kinetic turbidimetric LAL (Limulus Amebocyte Lysate) testing per USP <85> on sodium hyaluronate raw materials. Typical acceptance criteria:

HA application	Endotoxin limit	Rationale
Injectable filler (dermal)	≤ 0.5 EU/mL (reconstituted)	USP <85> / EP 2.6.14 requirement
Post-procedure topical	≤ 5.0 EU/mL (1% solution)	Risk-based; compromised barrier
Standard topical cosmetic	≤ 20 EU/mL (1% solution)	Supplier quality indicator
Raw material powder (incoming)	≤ 0.5 EU/mg	Covers all downstream uses

If you market for post-procedure use and your HA raw material has no endotoxin data, your claim outpaces your documentation. LAL testing on powder reconstituted at 1% in LAL reagent water takes 3–5 business days and costs a fraction of what a product liability claim would.

Viscosity as a release parameter

Viscosity is not just a sensory attribute — it is a functional release parameter that reflects MW integrity, concentration accuracy, and hydration state. A 1% sodium hyaluronate solution at 25 °C should produce viscosity within a defined range that correlates to the MW grade. Drift outside that range on a finished product batch signals either MW degradation, incorrect HA concentration, or a formulation interaction that altered the polymer’s hydrodynamic volume.

At Qalitex, we measure dynamic viscosity on a Brookfield DV2T rotational viscometer at 25 ± 0.5 °C using spindle and speed combinations selected to keep torque within the 10–90% range for optimal accuracy. For 1% aqueous sodium hyaluronate solutions:

MW grade	Expected viscosity (1% solution, 25 °C)	Spindle / speed
Low MW (< 50 kDa)	1–10 mPa·s	UL adapter / 60 RPM
Medium MW (100–500 kDa)	50–500 mPa·s	Spindle 62 / 30 RPM
High MW (> 1 MDa)	1,000–10,000 mPa·s	Spindle 64 / 6 RPM

Finished-product viscosity depends on HA concentration, pH, ionic strength, and co-ingredients. A hyaluronic acid serum at 0.5% high-MW HA might target 2,000–4,000 mPa·s as a release window, while the same serum reformulated with 0.1% low-MW HA might target 5–15 mPa·s. Set your release spec by running at least 5 conforming pilot batches and calculating the mean ± 3 SD range, then tighten to ± 2 SD once production stabilizes.

Shear-thinning behavior is expected for medium and high-MW grades. If your quality team measures at only one shear rate and your production viscometer operates at a different one, the numbers will not agree. Align on the exact measurement protocol — including equilibration time (60 seconds minimum after spindle reaches target speed) and sample temperature — between R&D, QC, and any contract lab.

Stability in aqueous systems

HA degrades in aqueous formulations through three primary pathways: thermal hydrolysis, radical-mediated chain scission, and enzymatic degradation from microbial contamination. Each pathway produces lower-MW fragments, which manifests as declining viscosity and, eventually, changes in sensory and efficacy claims.

Thermal hydrolysis accelerates above 40 °C and below pH 4.0 or above pH 8.0. Stability studies at 25 °C/60% RH (long-term) and 40 °C/75% RH (accelerated) per ICH Q1A should include both HA content by carbazole assay and viscosity at each time point: T0, 1 month, 3 months, 6 months, and 12 months. At Qalitex, we have observed 15–25% viscosity loss at 6 months/40 °C in unbuffered aqueous serums formulated at pH 5.0 — reformulating with a phosphate or citrate buffer at pH 6.0–7.0 typically holds viscosity loss under 10% at the same time point.

Radical-mediated degradation is triggered by transition metal ions (Fe²⁺, Cu²⁺), UV exposure, and peroxide-generating preservative systems. Ascorbic acid, a common co-ingredient in “vitamin C + HA” serums, generates radicals in the presence of trace metals. Brands combining HA with L-ascorbic acid should add EDTA disodium (0.05–0.1%) as a chelating agent and run viscosity at 3-month accelerated to confirm chain-length stability.

Microbial contamination introduces hyaluronidase activity. Preservative efficacy testing (PET) per USP <51> or ISO 11930 is non-negotiable for any aqueous HA product. “Preservative-free” serums relying solely on packaging (airless pumps, single-dose vials) still need microbial challenge data demonstrating the packaging strategy controls bioburden through shelf life.

Stability endpoints for an HA serum should include at minimum: appearance, pH, viscosity, HA content (carbazole or HPLC), microbial limits, and preservative efficacy at the terminal time point. If your stability protocol only tracks appearance and pH, you are missing the two parameters — viscosity and HA content — that directly measure whether the active ingredient survived.

Testing checklist for HA brands

1. Define MW acceptance criteria numerically — specify Mw range in kDa, not categorical labels, in your raw material specification and quality agreement with the supplier

2. Run SEC-HPLC on every new supplier qualification lot and annually thereafter — request the full chromatogram and PDI, not just the reported Mw value

3. Set protein residual limits at ≤ 0.1% for cosmetic grade — test by Bradford at 595 nm on every incoming lot from fermentation-derived sources

4. Add endotoxin testing by LAL for any post-procedure or barrier-compromised positioning — ≤ 0.5 EU/mg on raw material powder covers downstream applications

5. Include viscosity in your finished-product release spec — align measurement conditions (temperature, spindle, speed, equilibration time) across all testing sites

6. Run accelerated stability with viscosity and HA content endpoints — appearance and pH alone will not catch MW degradation

7. Validate preservative efficacy per USP <51> for every aqueous HA formula, including “preservative-free” formats relying on packaging controls

8. Require full CoA alignment between your internal specification and what your supplier provides — if your spec lists protein residuals and the supplier CoA does not, close that gap before accepting the lot

Sodium hyaluronate testing is not exotic analytical chemistry. SEC, LAL, Bradford, and viscometry are established methods available at any competent contract lab. The competitive advantage is in specification-setting: defining the numbers that separate a premium, well-characterized HA grade from a commodity lot that happens to pass a single-line assay.

Explore cosmetic testing and chemical testing and analysis for raw material and finished-goods release programs. For method development on non-compendial HA grades, see analytical method development and validation.

Editorial scope

This article summarizes common lab-testing considerations for brands and is not a substitute for product-specific regulatory or legal advice. Method availability and accreditation scope vary by project — confirm with Qalitex before relying on a test menu for release or registration.

Related: Lab testing for supplements: the complete brand guide.